Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of phenobarbital on biliary lipid metabolism and hepatic microsomal drug metabolism in patients with cholesterol cholelithiasis

  • 15 Accesses

  • 10 Citations

Abstract

Six patients with cholesterol cholelithiasis were studied before and after 3 weeks treatment with phenobarbital, 120 mg/day. The kinetics of cholic and chenodeoxycholic acid and biliary lipid composition were not significantly affected by phenobarbital treatment although hepatic mixed-function oxidase was stimulated by the treatment as shown by increased breath output of14CO 2 after administration of [14C]aminopyrine. It is concluded that treatment with phenobarbital is unlikely to be effective therapy for patients with cholesterol cholelithiasis.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Conney AH, Davidson C, Gastel R, Burns JJ: Adaptive increases in drug-metabolising enzymes induced by phenobarbital and other drugs. J Pharmacol Exp Ther 130:1–8, 1960

  2. 2.

    Bonorris GG, Coyne MJ, Goldstein LI, Schoenfield LJ: Chenodeoxycholic acid and phenobarbital effect the ratelimiting enzymes of cholesterol and bile acid synthesis in man. Gastroenterology (in press)

  3. 3.

    Bucher NLR, Overath P, Lynen F: Beta-hydroxy-betamethylglutaryl coenzyme A reductase, cleavage, and condensing enzymes in relation to cholesterol formation in rat liver. Biochim Biophys Acta 40:491–501, 1960

  4. 4.

    Lindstedt S: The formation of bile acids from 7-alpha-hydroxycholesterol in the rat. Acta Chem Scand 11:417–420, 1957

  5. 5.

    Mosbach EH, Rothschild MA, Begersky I, Oratz M, Mongelli J: Bile acid synthesis in the isolated, perfused rat liver. J Clin Invest 50:1720–1730, 1971

  6. 6.

    Shefer S, Hauser S, Bekersky I, Mosbach EH: Feedback regulation of bile acid biosynthesis in the rat. J Lipid Res 10:646–655, 1969

  7. 7.

    Redinger RN, Small DM: Primate biliary physiology VIII: The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion, and bile composition. J Clin Invest 52:161–172, 1973

  8. 8.

    Admirand WH, Small DM: The physiochemical basis of cholesterol gallstone formation in man. J Clin Invest 47:1043–1052, 1968

  9. 9.

    Vlahcevic ZR, Bell CC, Jr, Juttijudata P, Swell L: Bile-rich duodenal fluid as an indicator of biliary lipid composition and its applicability to detection of lithogenic bile. Am J Dig Dis 16:797–802, 1971

  10. 10.

    Redinger RN: The effect of phenobarbital on biliary lipid metabolism. Gastroenterolgy 66:73, 1974 (abstract)

  11. 11.

    Miller NE, Nestel PJ: Altered bile acid metabolism during treatment with phenobarbitone. Clin Sci Mol Med 45:257–262, 1973

  12. 12.

    Coyne MJ, Bonorris GG, Chung A, Goldstein LI, Lahana D, Schoenfield LJ: Treatment of gallstones with chenodeoxycholic acid and phenobarbital. N Engl J Med 292:604–607, 1975

  13. 13.

    Hepner GW: The effect of decreased gallbladder stimulation on enterohepatic cycling and kinetics of bile acids. Gastroenterology 68:1574–1581, 1975

  14. 14.

    Talalay P: Enzymic analysis of steroid hormones. Methods Biochem Anal 8:119–143, 1960

  15. 15.

    Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66:373–400, 1925.

  16. 16.

    Carpenter KJ, Gotsis A, Hegsted DM: Estimation of total cholesterol by a micro method. Clin Chem 3:233–238, 1957

  17. 17.

    Thomas PJ, Hofmann AF: A simple calculation of the lithogenic index of bile: Expressing biliary lipid composition on rectangular coordinates. Gastroenterology 65:698–700, 1973

  18. 18.

    Holzbach RT, Marsh M, Olszewski M, Holan K: Cholesterol solubility in bile: Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 52:1467–1479, 1973

  19. 19.

    Hepner GW, Vesell ES: Assessment of aminopyrine metabolism in man by breath analysis after oral administration of14C-aminopyrine: Effects of phenobarbital, disulfiram and portal cirrhosis. N Engl J Med 291:1384–1388, 1974

  20. 20.

    Hepner GW, Vesell ES: Quantitative assessment of hepatic function in man by breath analysis after oral administration of14C-aminopyrine. Ann Intern Med 83:632–638, 1975

  21. 21.

    Gregory DH, Vlahcevic ZR, Swell L: Determination of the cholesterol saturation of human bile and its relevance to gallstone formation. Am J Dig Dis 19:268–270, 1974

  22. 22.

    Vlahcevic ZR, Bell CC Jr, Buhac I, Farrar JT, Swell L: Diminished bile acid pool size in patients with gallstones. Gastroenterology 59:165–173, 1970

  23. 23.

    Ginsberg RL, Garnick MB: Effect of phenobarbital on biliary lipid metabolism in man. Gastroenterology. 68:899, 1975 (abstract)

  24. 24.

    Hunter J, Maxwell JD, Carella M, Stewart DA, Williams R: Urinaryd-glucaric acid excretion as a test for hepatic enzyme induction in man. Lancet 1:572–575, 1971

  25. 25.

    Williams R, Hunter J, Maxwell JD: Measurement of hepatic enzyme induction in man: Use ofd-glucaric acid excretion test. The Liver; Quantitative Aspects of Structure and Function. G Paumgartner, R Preisig, (eds). Karger, Basel, 1973, pp 224–231

  26. 26.

    Hepner GW, Quarfordt SH: The kinetics of cholesterol and bile acids in patients with cholesterol cholelithiasis. Gastroenterology 69:000, 1975

  27. 27.

    Bell GD, Dowling RH, Whitney B, Sutor DJ: The value of radiology in predicting gallstone type when selecting patients for medical treatment. Gut 16:359–364, 1975

  28. 28.

    Trotman BW, Petrella EJ, Soloway RD, Sanchez HM, Morris TA, III, Miller WT: Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones. Correlation of lucency or opaqueness with calcium and mineral. Gastroenterology 68:1563–1566, 1975

  29. 29.

    Hapner GW, Vesell ES: Normal antipyrine metabolism in patients with cholesterol cholelithiasis: Evidence that the disease is not due to generalized hepatic microsomal dysfunction. Am J Dig Dis 20:9–12, 1975

  30. 30.

    Banfield WJ, Admirand WH: The nature of the defect of bile acid (BA) metabolism in cholesterol cholelithiasis (CC). Clin Res 23:245, 1975 (abstract)

  31. 31.

    Coyne MJ, Bonorris GG, Goldstein LI, Schoenfield LJ: Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med 87:281–291, 1976

Download references

Author information

Correspondence to Dr. Gershon W. Hepner MD.

Additional information

This work was supported in part by grant AM 17303 from the National Institutes of Health.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hepner, G.W. The effect of phenobarbital on biliary lipid metabolism and hepatic microsomal drug metabolism in patients with cholesterol cholelithiasis. Digest Dis Sci 21, 370–375 (1976). https://doi.org/10.1007/BF01072658

Download citation

Keywords

  • Public Health
  • Lipid
  • Cholesterol
  • Lipid Metabolism
  • Drug Metabolism